Table 4 Pyridine (11a–d) derived annelated benzazepines (13a–d)
Entry
1
Pyridine 11
Enamine 12 (%)a,b
Benzazepine 13 (%)c
11a
11b
12a (60)
12b (75)
13a (60)
13b (63)
13c (61)
2
3
Fig. 2 X-Ray crystal structure of 13d.
Scheme 2
Laura A. T. Cleghorn,a Ronald Grigg,*a Colin Kilner,a
12c (82)
12d (64)
11c
11d
William S. MacLachlanb and Visvanthar Sridharana
4
aMolecular Innovation, Diversity and Automated Synthesis (MIDAS)
Centre, School of Chemistry, Leeds University, Leeds, UK LS2 9JT.
E-mail: R.Grigg@chem.leeds.ac.uk; Fax: 0113 343 6530;
Tel: 0113 343 6501
bGlaxoSmithKline, New Frontiers Science Park (North), Third Avenue,
Harlow, UK CM19 5AW
13d (72)
a
Yield calculated using an internal standard of MeOH 1 mmol/2 ml
CDCl3. Thiophene (2 mol eq.) used as an additional additive.
Isolated yield for the reduction of (12) to (13).
b
Notes and references
c
{ Crystallographic data: 7g (C26H25N), M 5 351.47, orthorhombic,
3
˚
˚
a 5 10.3740(2), b 5 19.2830(7), c 5 9.7330(3) A, V 5 1947.01(10) A ,
T 5 150(2) K, space group Pna21, Z 5 4, m 5 0.069 mm21, R1 5 0.0395,
wR2 5 0.1031 for 10989 reflections, CCDC 266425. 13d (C19H19NO),
Table 5 Class 1 inter–inter 1,2,3,4-tetrahydroisoquinoline (17)
˚
M 5 277.35, monoclinic, a 5 10.0020(3), b 5 13.1350(4), c 5 10.9480(4) A,
3
˚
V 5 1436.56(8) A , T 5 150(2) K, space group P21/c, Z 5 4, m 5
1,2-
Dihydroisoquinoline Tetrahydroisoquinoline
16 (%)a 17 (%)b
1,2,3,4-
0.079 mm21, R1 5 0.0419, wR2 5 0.1166 for 12805 reflections, CCDC
graphic data in CIF or other electronic format.
Aryl
Entry iodide
1
1 M. Shama and M. J. Hillman, Tetrahedron, 1971, 27, 1363.
2 R. Suau, J. M. Lo´pez-Romero, A. Ruiz and R. Rico, Tetrahedron, 2000,
56, 993.
3 J. Miyata, H. Natashima, H. Nemoto, H. Kim, Y. Wataya and
M. Ihava, Heterocycles, 1998, 49, 101.
4 T. Itoh, K. Nagata, M. Yokoya, M. Miyazaki, K. Kameoka,
S. Nakamura and A. Ohsawa, Chem. Pharm. Bull., 2003, 51, 951.
5 U. Anwar, R. Grigg, M. Rasparini, V. Savic and V. Sridharan, Chem.
Commun., 2000, 645.
17a (36)
16a (49)
6 U. Anwar, R. Grigg and V. Sridharan, Chem. Commun., 2000, 933.
7 I. R. Cooper, R. Grigg, M. J. Hardie, W. S. MacLachlan, V. Sridharan
and W. A. Thomas, Tetrahedron Lett., 2003, 44, 2283.
8 I. R. Cooper, R. Grigg, W. S. MacLachlan, M. Thornton-Pett and
V. Sridharan, Chem. Commun., 2002, 1372.
2
9 J. A. Marshall and C. M. Grant, J. Org. Chem., 1999, 64, 8214.
10 S. Araki, T. Kamei, T. Hirashita, M. Kawai, H. Yamamura and
H. Kawai, Org. Lett., 2000, 2, 847–849.
11 S. Araki, T. Hirashita, M. Kawai and H. Yamamura, Chem. Commun.,
2001, 387.
12 S. Araki, K. Kameda, J. Tananka, T. Hirashita, H. Yamamura and
M. Kawai, J. Org. Chem., 2001, 66, 7919.
16b (71)
17b (47)
3
13 T. Loh, P. Lye, R. Wang and K. Sim, Tetrahedron Lett., 2000, 41, 7779.
14 L. A. T. Cleghorn, I. R. Cooper, C. W. G. Fishwick, R. Grigg,
W. S. MacLachlan, M. Rasparini and V. Sridharan, J. Organomet.
Chem., 2003, 687, 483.
15 L. A. T. Cleghorn, I. R. Cooper, R. Grigg, W. S. MacLachlan and
V. Sridharan, Tetrahedron Lett., 2003, 44, 7969.
16 J. Cossy, L. Tresnard and D. Gomez Pardo, Eur. J. Org. Chem., 1999,
1925.
17 J. Yang, W. Hua, F. Wang, Z. Wang and X. Wang, Bioorg. Med.
Chem., 2004, 12, 6547.
16c (70)
17c (48)
a
Yield calculated using an internal standard of MeOH 1 mmol/2 ml
CDCl3 Isolated yield for the reduction of (16) to (17)
b
This journal is ß The Royal Society of Chemistry 2005
Chem. Commun., 2005, 3071–3073 | 3073